Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study

OBJECTIVE: To assess the effects of subcutaneous (sc) interferon (IFN) -1a on cognition over 5 years in mildly disabled patients with relapsing–remitting multiple sclerosis (RRMS). METHODS: Patients aged 18–50 years with RRMS (Expanded Disability Status Scale score ≤4.0) who had completed the 3-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Francesco, Morra, Vincenzo Brescia, Amato, Maria Pia, Trojano, Maria, Bastianello, Stefano, Tola, Maria Rosalia, Cottone, Salvatore, Plant, Andrea, Picconi, Orietta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796707/
https://www.ncbi.nlm.nih.gov/pubmed/24137499
http://dx.doi.org/10.1371/journal.pone.0074111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796707/
https://www.ncbi.nlm.nih.gov/pubmed/24137499
http://dx.doi.org/10.1371/journal.pone.0074111

Ejemplares similares